While the most common uses of 'magic mushrooms' might strike politicians as frivolous, that doesn't mean they should treat ...
Opinion
Creators Syndicate on MSNOpinion
The Perils of Viewing Psilocybin Strictly as a Psychiatric Medication: The Most Common Uses of 'Magic Mushrooms' Will Never Gain FDA Approval
The Scottsdale Research Institute grows psilocybin mushrooms in Arizona with permission from the Drug Enforcement Administration. Late last month, the organization announced that it will use those ...
RUNAWAY BAY, Jamaica, Dec. 12, 2023 (GLOBE NEWSWIRE) -- Rose Hill (or the âCompanyâ), a premium psilocybin cultivator, supplier processor, and exporter in Jamaica, has announced a groundbreaking ...
A new scientific review published by the American Medical Association (AMA) shows that use of psilocybin has âsurgedâ in the ...
The nationâs first clinical trials testing if whole psilocybin mushrooms can treat post-traumatic stress are scheduled to soon start in metro Phoenix. Study participants will include firefighters, ...
Research suggests psilocybin may ease obsessive-compulsive behaviors, offering fast, lasting relief after a single dose.
Drug developer Compass Pathways said on Tuesday it is pulling forward the expected launch of its experimental psilocybin-based depression therapy by 9 to 12 months, sending its shares nearly 6% higher ...
News Medical on MSN
Systematic analysis reveals psilocybin's impact on obsessive-compulsive behaviors
A systematic review published today in Psychedelics by Mr. James Gattuso and colleagues at the Florey Institute of Neuroscience and Mental Health synthesizes clinical and preclinical evidence on ...
VANCOUVER, British Columbia, April 02, 2024 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a leading Health Canada licensed psychedelics pharmaceutical manufacturer, ...
TipRanks on MSN
Compass Pathwaysâ Psilocybin Study: A Potential Game-Changer for Treatment-resistant Depression
Compass Pathways Plc (($CMPS)) announced an update on their ongoing clinical study. Compass Pathways Plc is conducting a Phase III clinical study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results